Recent Patents on Anti-Cancer Drug Discovery

Papers
(The TQCC of Recent Patents on Anti-Cancer Drug Discovery is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Acknowledgement to Contributors36
Current Prospects for Adrenocortical Carcinoma Pharmacotherapy22
Acknowledgement to Reviewers22
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies20
N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer16
High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer16
Patent Selections15
Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival15
Research Progress on the Anticancer Activity of Plant Polysaccharides15
Comprehensive Genomic Analysis of Puerarin in Inhibiting Bladder Urothelial Carcinoma Cell Proliferation and Migration15
Santacruzamate A Compositions, Analogs and Methods of Use: A Patent Evaluation of WO 2014/018913 (A2)14
The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking14
The Prognostic Role of Interferon Gamma-inducible Protein 30 in Clear Cell Renal Cell Carcinoma with Immune Infiltrates14
The Application of Nanotechnology in Immunotherapy based Combinations for Cancer Treatment13
Nanomaterials for Diagnosis and Treatment of Lung Cancer: A Review of Recent Patents13
Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer13
Radiotherapy Enhancing and Radioprotective Properties of Berberine: A Systematic Review13
Prognostic Value of Fatty Acid Metabolism-related Genes in Patients with Bladder Cancer13
Alpha-solanine Anti-tumor Effects in Non-small Cell Lung Cancer Through Regulating the Energy Metabolism Pathway12
Acknowledgement To Reviewers12
Vitexin’s Role in Colon Cancer Apoptosis: AMPK/mTOR Pathway Modulation Explored Through Experimental and Computational Approaches11
USP31 Activates the Wnt/β-catenin Signaling Pathway and Promotes Gastric Cancer Cell Proliferation, Invasion and Migration11
Bourgeoning Cancer Targets10
STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells10
Mechanisms of Anti-PD Therapy Resistance in Digestive System Neoplasms10
Integrated Single-cell and Bulk RNA Sequencing Analysis Cross Talk between Ferroptosis-related Genes and Prognosis in Oral Cavity Squamous Cell Carcinoma10
The Causal Effects of Cholelithiasis on Acute Pancreatitis and Pancreatic Cancer: A Large Sample Size Mendelian Randomization Analysis10
Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment10
Patent Selections9
Predictive Modelling of Overall Survival in Adult Patients with Primary Diffuse Large B-cell Lymphoma of the Breast Using the Surveillance, Epidemiology, and End Results (SEER) Database9
Antioxidant, Anti-Inflammatory and Anticancer Activities of the Methanolic Extract of Thottea siliquosa: An In Vitro and In Silico Study9
Recent Trend for EGFR-Based and ALK-Based Targets: A Patent Analysis9
Intracholecystic Papillary-tubular Neoplasm (ICPN) of the Gallbladder: A Case Report Focusing on an Unexpected Pathological Finding8
Puerarin: An Anticancer and Anti-Inflammatory Agent8
Prospective Challenges for Patenting and Clinical Trials of Anticancer Compounds from Natural Products: Coherent Review8
Construction and Identification of a Human Colorectal Adenoma Epithelial Cell Line by SV40 Large T-Antigen Transfection8
Patent Selections8
Meet the Editorial Board Member8
The m6A Reader IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression by Maintaining UCA1 Stability8
Current Status and Prospects of Camrelizumab, A Humanized Antibody Against Programmed Cell Death Receptor 18
lncRNA H22954 Inhibits Angiogenesis in Acute Myeloid Leukemia through a PDGFA-dependent Mechanism7
Application of Nano Drug Delivery System (NDDS) in Cancer Therapy: A Perspective7
The Synergistic Effect of Ruthenium Complex Δ-Ru1 and Doxorubicin in a Mouse Breast Cancer Model7
Targeted Regulation of Osteoblasts and Osteoclasts in Osteosarcoma Patients by CSF3R Receptor Inhibition of Osteolysis Caused by Tumor Inflammation Based on Transcriptional Spectrum Analysis and Drug 7
Ubiquitination-related Gene UBTD1 Mediates Poor Prognosis of Colorectal Cancer and Affects Colorectal Cancer Cell Proliferation and Ferroptosis7
Natural STAT3 Inhibitors for Cancer Treatment: A Comprehensive Literature Review7
The FJQR Has Synergistic Effect with Fluoropyrimidine in the Maintenance Treatment for HER-2 Negative Gastric Cancer7
Patent Selections7
Circular RNA NF1-419 Inhibits Proliferation and Induces Apoptosis by Regulating Lipid Metabolism in Astroglioma Cells7
Metallodrugs as Anticancer Chemotherapeutics and Diagnostic Agents: A Critical Patent Review (2010-2020)7
SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways7
Preface7
Prognostic and Therapeutic Values of Autophagy-related Genes in Triple-negative Breast Cancer6
A Synergistic Combination of Oleanolic Acid and Apatinib to Enhance Antitumor Effect on Liver Cancer Cells and Protect against Hepatic Injury6
pH-responsive Sulfated Hyaluronic Acid Nanoparticles Targeting Tumor Cells and CAFs for the Treatment of Breast Cancer6
Targeting Notch Pathway in Cancer Diagnostics and Therapeutics: An Emerging Approach6
Adverse Effects of Gefitinib on Skin and Colon in a Lung Cancer Mouse Model6
Advances in the Treatment of Chronic Myeloid Leukemia6
KRAS Pathways: A Potential Gateway for Cancer Therapeutics and Diagnostics6
Development of a Novel Lipid Metabolism-related Gene Prognostic Signature for Patients with Colorectal Cancer6
Patent Selections6
Fatty Acid Synthase (FASN): A Patent Review Since 2016-Present6
Exploring the Anticancer Potentials of Polyphenols: A Comprehensive Review of Patents in the Last Five Years6
Investigating the Therapeutic Potential and Molecular Mechanisms of Daphnetin: A Comprehensive Review6
Patent Selections6
UBE2L3 Suppresses Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression6
0.059041023254395